BOCA RATON, Fla.--(BUSINESS WIRE)--SurGenTec, a privately held spine and orthopedic technology company, announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Ventris Medical received FDA 510(k) clearance of its ...
NEWPORT BEACH, Calif., March 13, 2024 /PRNewswire/ -- Ventris Medical, a privately held orthobiologics and tissue regeneration company, today announced that the United States Food and Drug ...
MagnetOs ™ Granules becomes the third product in the MagnetOs portfolio to receive FDA clearance to market for interbody use Kuros continues expansion of the MagnetOs franchise with launch of MagnetOs ...
After Novosis Putty gained U.S. FDA breakthrough device designation of bio-fusion spine implantation device, South Korea’s Cgbio Co. Ltd. posted positive findings of similar ceramic bone graft, ...
Korean med-tech firm Innosys Co. Ltd. recently launched two new injectable spine bone graft substitute products – Velofuse Gel and Velofuse Putty – and announced a name change to CG Medtech Co. Ltd., ...
ZURICH, SWITZERLAND / ACCESSWIRE / January 4, 2024 / Kuros Biosciences, a leader in next generation bone graft technologies, announced today three advancements related to its MagnetOs portfolio of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results